Parenting Intervention Program for Acute Leukemia and Lymphoblastic Lymphoma
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What data supports the effectiveness of the High-Intensity Parent Intervention Program treatment for acute leukemia and lymphoblastic lymphoma?
Research shows that parenting interventions can help improve child behavior and family coping in cases of childhood leukemia. Studies have found that such programs can lead to better compliance with treatment and reduce stress in parents, which may indirectly benefit children undergoing treatment for leukemia.12345
Is the Parenting Intervention Program for Acute Leukemia and Lymphoblastic Lymphoma safe for participants?
How does the Parenting Intervention Program for Acute Leukemia and Lymphoblastic Lymphoma differ from other treatments?
The Parenting Intervention Program is unique because it focuses on helping parents manage the emotional and behavioral challenges their children face during leukemia treatment, rather than directly treating the disease itself. This program includes group videoconferencing and structured support groups to improve coping skills and reduce psychological distress, which is not typically addressed by standard medical treatments for leukemia.12789
What is the purpose of this trial?
This randomized clinical trial studies how well a high-intensity intervention parenting program works in improving learning and school functioning in Latino children with acute leukemia or lymphoblastic lymphoma. A high-intensity intervention program may help doctors to see whether training parents or caregivers in specific parenting skills and "pro-learning" behaviors will result in better learning and school outcomes for Latino children with acute leukemia or lymphoblastic lymphoma. It is not yet known if a high-intensity intervention program is more beneficial than a standard of care lower intensity parenting intervention.
Research Team
Sunita Patel
Principal Investigator
City of Hope Medical Center
Eligibility Criteria
This trial is for Latino children aged 5-12 who have been treated for acute leukemia or lymphoblastic lymphoma, and their parents/caregivers. The caregivers must be the primary ones, in daily contact with the child, self-identify as Hispanic/Latino, and speak Spanish. Children should understand English and be enrolled in school. Those with severe neurodevelopmental disorders or involved in similar studies are excluded.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Parents or caregivers attend either a high-intensity intervention program (HIP) or a standard of care lower intensity intervention program (LIP). HIP involves individual parental skill training sessions every 2 weeks for a total of 8 sessions, while LIP consists of a single session to review neurocognitive evaluation results.
Follow-up
Participants are monitored for learning and school functioning outcomes, as well as parental efficacy and pro-learning behaviors, up to 12 months post enrollment.
Treatment Details
Interventions
- High-Intensity Parent Intervention Program
Find a Clinic Near You
Who Is Running the Clinical Trial?
City of Hope Medical Center
Lead Sponsor
National Cancer Institute (NCI)
Collaborator